📰 Diagnostic Development News
Page 2 - Diagnostic Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diagnostic Development. Real-time updates on events, politics, business and more.
October 6, 2021
Poster presentation by Pr. Christophe Le Tourneau featuring first OS and PFS data from phase I expansion study of NBTXR3 as a single agent activated by radiotherapy in tough-to-treat HNSCC population
April 28, 2021
(1) New data with additional patients and further follow up from Study 1100, evaluating lead product candidate NBTXR3 in combination with anti-PD-1 in head and neck cancer, lung metastasis and/or liver metastasis New data with additional patients and further follow up on safety and response rate from Study 102 dose expansion, evaluating NBTXR3 as a single agent activated by radiotherapy in head and neck cancer Long term safety data from complete European phase II/III registration study, Act.In....
April 13, 2021
Today, Amazon Web Services (AWS) launched the next phase of Diagnostic Development Initiative and expanded funding scope.